Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20123
20131
20191
20203
20221
20231
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed4
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
GlaxoSmithKline2
Astex Pharmaceuticals, Inc.1
Bayer1
Celcuity Inc1
CureVac1
Epizyme, Inc.1
Genentech, Inc.1
Genmab1
Maastricht University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms19
Breast Neoplasms4
Ovarian Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Pancreatic Neoplasms3
Triple Negative Breast Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Head and Neck Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.